Kymera Therapeutics

formerly KymeraIPO

Kymera Therapeutics is a biotech company in Boston, United States, founded in 2016. It has raised $197.0M across 3 rounds, most recently a $102.0M Series C in March 2020.

Revolutionary Medicines Catalyzed by Protein Degradation

Employees
51–200
Founded
2016
Business Model
Other
Total Funding
$197.0M
Last Round
$102.0M Series CMar 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Kymera Therapeutics is a clinical-stage biotechnology company pioneering targeted protein degradation to develop oral small molecule medicines addressing critical health problems in immunology and oncology. Its proprietary platform enables degradation of disease-causing proteins, transforming treatment paradigms for undruggable targets.

Summary

It lists 51–200 employees. It has raised $197.0M in total across 3 rounds, most recently a $102.0M Series C round in Mar 2020. Investors include Biotechnology Value Fund, Redmile Group and Atlas Venture.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPODec 2025
$602.0M

Sign up to see all 6 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kymera Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/kymera-therapeutics"><img src="https://indexed.vc/api/badge/company/kymera-therapeutics" alt="Kymera Therapeutics on Indexed.vc" width="260" height="76" /></a>